Continuous vaccinations of 4Aβ1-15 induces specific fluctuation of inflammatory factors accompany with pathologic alterations alleviation in APP/PS1 mice

References

• Robert R, Wark KL. Engineered antibody approaches for Alzheimer's disease immunotherapy. Arch Biochem Biophys 2012; 526:132-8; PMID:22475448; http://dx.doi.org/10.1016/j.abb.2012.02.022
   PubMed Web of Science ®Google Scholar
• Lemere CA. Immunotherapy for Alzheimer's disease: hoops and hurdles. Mol Neurodegener 2013; 8:36; PMID:24148220; http://dx.doi.org/10.1186/1750-1326-8-36
   PubMed Web of Science ®Google Scholar
• Mohajeri MH, Saini K, Schultz JG, Wollmer MA, Hock C, Nitsch RM. Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation. J Biol Chem 2002; 277:33012-7; PMID:12068009; http://dx.doi.org/10.1074/jbc.M203193200
   PubMed Web of Science ®Google Scholar
• Guan X, Zou J, Gu H, Yao Z. Short amyloid-beta immunogens with spacer-enhanced immunogenicity without junctional epitopes for Alzheimer's disease immunotherapy. Neuroreport 2012; 23:879-84; PMID:22922658; http://dx.doi.org/10.1097/WNR.0b013e328358a044
   PubMed Web of Science ®Google Scholar
• Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6:916-9; PMID:10932230; http://dx.doi.org/10.1038/78682
   PubMed Web of Science ®Google Scholar
• Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13:1359-62; PMID:17934472; http://dx.doi.org/10.1038/nm1653
   PubMed Web of Science ®Google Scholar
• Folkesson R, Malkiewicz K, Kloskowska E, Nilsson T, Popova E, Bogdanovic N, Ganten U, Ganten D, Bader M, Winblad B, et al. A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. Biochem Biophys Res Commun 2007; 358:777-82; PMID:17506994; http://dx.doi.org/10.1016/j.bbrc.2007.04.195
   PubMed Web of Science ®Google Scholar
• Browne TC, McQuillan K, McManus RM, O'Reilly JA, Mills KH, Lynch MA. IFN-gamma Production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. J Immunol 2013; 190:2241-51; PMID:23365075; http://dx.doi.org/10.4049/jimmunol.1200947
   PubMed Web of Science ®Google Scholar
• Guan X, Yang J, Gu H, Zou J, Yao Z. Immunotherapeutic efficiency of a tetravalent Abeta1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease. Hum Vaccin Immunother 2013; 9:1643-53; PMID:23732905; http://dx.doi.org/10.4161/hv.24830
   PubMed Web of Science ®Google Scholar
• Xing X, Sha S, Li Y, Zong L, Jiang T, Cao Y. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation. J Neurol Sci 2012; 313:17-21; PMID:22029939; http://dx.doi.org/10.1016/j.jns.2011.09.040
   PubMed Web of Science ®Google Scholar
• Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, Cohen H, Schwartz M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A 2006; 103:11784-9; PMID:16864778; http://dx.doi.org/10.1073/pnas.0604681103
   PubMedGoogle Scholar
• Du J, Sun B, Chen K, Fan L, Wang Z. Antagonist of peroxisome proliferator-activated receptor gamma induces cerebellar amyloid-beta levels and motor dysfunction in APP/PS1 transgenic mice. Biochem Biophys Res Commun 2009; 384:357-61; PMID:19422805; http://dx.doi.org/10.1016/j.bbrc.2009.04.148
   PubMed Web of Science ®Google Scholar
• Gruden MA, Davidova TB, Malisauskas M, Sewell RD, Voskresenskaya NI, Wilhelm K, Elistratova EI, Sherstnev VV, Morozova-Roche LA. Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters. J Neuroimmunol 2007; 186:181-92; PMID:17477976; http://dx.doi.org/10.1016/j.jneuroim.2007.03.023
   PubMed Web of Science ®Google Scholar
• Park SM, Shin JH, Moon GJ, Cho SI, Lee YB, Gwag BJ. Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice. BMC Neurosci 2011; 12:106; PMID:22029666; http://dx.doi.org/10.1186/1471-2202-12-106
   PubMed Web of Science ®Google Scholar
• Ahmed AA, Subaiea MG, Eid A, Li L, Seeram PN, Zawia HN. Pomegranate Extract Modulates Processing of Amyloid-beta Precursor Proteinin an Aged Alzheimer's Disease Animal Model. Curr Alzheimer Res 2014; 11(9):834-43; PMID:25274111
   PubMed Web of Science ®Google Scholar
• Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 2006; 9:268-75; PMID:16415867; http://dx.doi.org/10.1038/nn1629
   PubMed Web of Science ®Google Scholar
• Galea E, Heneka MT, Dello Russo C, Feinstein DL. Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol 2003; 23:625-35; PMID:14514020; http://dx.doi.org/10.1023/A:1025084415833
   PubMed Web of Science ®Google Scholar
• Gimsa U, Wolf SA, Haas D, Bechmann I, Nitsch R. Th2 cells support intrinsic anti-inflammatory properties of the brain. J Neuroimmunol 2001; 119:73-80; PMID:11525802; http://dx.doi.org/10.1016/S0165-5728(01)00343-5
   PubMed Web of Science ®Google Scholar
• Lok K, Zhao H, Shen H, Wang Z, Gao X, Zhao W, Yin M. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background. Neurosci Lett 2013; 557 Pt B:84-9; PMID:24176881; http://dx.doi.org/10.1016/j.neulet.2013.10.051
   PubMedGoogle Scholar
• Wilcock DM, Jantzen PT, Li Q, Morgan D, Gordon MN. Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid. Neuroscience 2007; 144:950-60; PMID:17137722; http://dx.doi.org/10.1016/j.neuroscience.2006.10.020
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer EG. Inflammation of the brain in Alzheimer's disease: implications for therapy. J Leukoc Biol 1999; 65:409-15; PMID:10204568
   PubMed Web of Science ®Google Scholar
• He F, Zou JT, Zhou QF, Niu DL, Jia WH. Glatiramer acetate reverses cognitive deficits from cranial-irradiated rat by inducing hippocampal neurogenesis. J Neuroimmunol 2014; 271:1-7; PMID:24713401; http://dx.doi.org/10.1016/j.jneuroim.2014.03.015
   PubMed Web of Science ®Google Scholar
• Xia Y, Qi F, Zou J, Yang J, Yao Z. Influenza vaccination during early pregnancy contributes to neurogenesis and behavioral function in offspring. Brain Behav Immun 2014; PMID:25014010
   PubMed Web of Science ®Google Scholar
• Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006; 1:848-58; PMID:17406317; http://dx.doi.org/10.1038/nprot.2006.116
   PubMed Web of Science ®Google Scholar
• Wiessner C, Wiederhold KH, Tissot AC, Frey P, Danner S, Jacobson LH, Jennings GT, Lüönd R, Ortmann R, Reichwald J, et al. The second-generation active Abeta immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects. J Neurosci 2011; 31:9323-31; PMID:21697382; http://dx.doi.org/10.1523/JNEUROSCI.0293-11.2011
   PubMed Web of Science ®Google Scholar